Open Nav
2016 Advisory Committee

Reginaldo Arcuri, President, Grupo FarmaBrasil (Brazil)


Fred Aslan, Vice President, Venrock Associates / Board Member, BayBrazil (USA)


Antonio Britto, President, Interfarma

As a journalist, he worked for the most important Brazilian network, Rede Globo, as a political commentator and responsible for the coverage of the Presidency and the Federal Congress for six years. He also worked for some of the major newspapers and magazines in the country. In 1985, he was invited to be the Press Secretary for Tancredo Neves, the first civil president after the military period. After this period as a journalist, Britto started a political career. He was Federal Representative for two terms, during eight years.

He worked as one of the main leaders in the writing the current Brazilian Constitution. He especially coordinated the chapters about Communication, Science and Technology and Social Security, being the Federal Minister of Social Security from 1992 to 1994. In the same year, elected Governor of the State of Rio Grande, one of the four largest states in Brazil. At this time, he resigned to run for the Presidency (when he shared the first place in the surveys with Mr. Luis Ignacio Lula da Silva) to support Mr. Fernando Henrique Cardoso. For the past ten years, he has been working as an executive for private companies.

He was the Azaleia´s CEO (a shoe manufacturer that leads the Brazilian market), a member of the Board of Directors for Claro (a telecommunication operator owned by Carlos Slim´s group) and a member of the board of Braskem, the major Latin American petrochemical corporation. He has been in charge of the Executive Presidency of Interfarma since May 2009.

Britto is married and has triplets.

Rodrigo Correa-Oliveira, Partner and Researcher, Nanomark and Oncologics (Brazil)

Rodrigo Correa-Oliveira, Ph.D. has a Bachelor of Science in Biology with a Master of Science in Biochemistry, from the Universidade Federal de Minas Gerais in Brazil, and is a Ph.D. in Immunology from the Johns Hopkins University in the USA. He is a Senior Researcher and Leader of the Laboratory of Cellular and Molecular Immunology of the Centro de Pesquisas René Rachou – FIOCRUZ, in Belo Horizonte, Minas Gerais, Bazil. He was the Director of FIOCRUZ in Minas Gerais from 2008 to 2012. Dr. Correa-Oliveira is a member of the Brazilian Academy of Sciences and of The World Academy of Sciences (TWAS). He is an Adjunct Professor of the George Washington University in Washington DC, of the Texas Biomedical Research Institute in San Antonio Texas, Visiting Professor at the Universidade Federal de Ouro Preto in Minas Gerais and a Volunteer Professor at the School of Nursing of the Universidade Federal de Minas Gerais.

He has served on various committees in Brazil and international organizations, such as the World Health Organization, European Commission, National Research Council – CNPq, Minas Gerais State Research Council - FAPEMIG. He was a member of a number of committees of the Special Program for Research and Training in Tropical Diseases – TDR of the World Health Organization and Vice-President of the Board form 2003-2005. He was a member of the Board of Trustees of the Minas Gerais State Research Foundation from 2011-2013 and During 20 years he served as member of different committees of the TDR-WHO, was the Chair of the Pathogenesis Committee for 6 years, The Vaccine Development Committee, Schistosomiasis Committee and appointed to represent Brazil on the TDR’s Joint Coordinating Board for 5 years and of the Pan American Health Organization – PAHO for 3 years.

His research aims to understand the role of different immune mechanisms involved in the development of pathology and also to identify mechanisms that are related to the development of resistance to infection, post-treatment reinfection as well as the role of co-infections on the human immune response and disease outcome. His group also develops programs on the understanding of the dynamics of these infections/reinfections by including the socio determinants of health, spatial statistics, population genetics, health education, accessibility to health and more recently mathematical modeling for prediction of disease risk.

Andrea Carla Barreto Cunhaon, Director of Technical Affairs, ABIQUIM

Gabriel Di Blasi, Partner, Di Blasi, Parente & Associados (Brazil)

Gabriel Di Blasi is an Industrial engineer, lawyer and Industrial Property agent, whose practice covers Brazilian and international intellectual property issues, including  patents, designs, trade secrets, protection of plant varieties, licensing and franchising, technology management and technological innovation.

His experience in Intellectual Property includes cases before the Brazilian Patent and Trademark Office (BPTO) and regulatory issues before the Ministry of Agriculture and National Health Surveillance Agency (ANVISA), as well as litigation involving data exclusivity, patents, designs, trade secrets and copyrights. Further, Mr. Di Blasi provides counseling on technology management and makes appearances before the government agencies responsible for Brazilian bio-diversity, among others.

Assistant Legal Director of the Brazilian Franchising Association of Rio de Janeiro, Mr. Di Blasi also holds the title of co-chairman of the CET 2 (Design) Commission of the International Federation of Intellectual Property Attorneys (FICPI); and he is a member and the responsible for intellectual and regulatory property affairs of the Biotechnology Commission - BIOBRASIL of the Federation of Industries of São Paulo State - FIESP.

Meredith Fensom, Director, Government Affairs, Intrexon (USA)

Meredith Fensom serves as the Intrexon Corporation’s Director for Government Affairs. Intrexon's mission is to address some of the world's greatest challenges through the application of biology.

Ms. Fensom's positions before joining Intrexon include serving as the Biotechnology Innovation Organization (BIO) founding Director for International Affairs and lead for Latin America; manager of an agricultural trade business and policy consulting firm; Special Assistant in the Office of the U.S. Trade Representative’s Office of the Americas; and founding Director of the University of Florida’s Law & Policy in the Americas Program. She has served as a consultant to various multinational institutions including the Inter-American Development Bank, the United Nations’ International Trade Centre and the World Bank.

Ms. Fensom has litigated matters of international law and was a Fulbright Scholar in Santiago, Chile, where she assisted in the design and evaluation of Chile’s judicial reform process. She also received CIBER and FLAS Fellowships to Brazil. She is fluent in Spanish and conversant in Portuguese.

Ms. Fensom received a J.D. from the University of Florida Levin College of Law and is a member of the District of Columbia and Florida Bars. She received a Master’s Degree from the University of Florida Center for Latin American Studies. Her undergraduate degree is from Furman University, with a major in Political Science and concentration in Latin American Studies. She is Secretary of the University of Florida’s Center for Latin American Studies Alumni Advisory Board and serves on the Americas Health Foundation Advisory Board.

Pedro Luiz Fernandes, Vice President of Corporate Affairs & Sustainability, Latin America, Novozymes

Mr. Fernandes is Novozymesí Vice President of Corporate Affairs & Sustainability for LA. He is also director of the Danish-Brazilian Chamber of Commerce (DANCHAMB) in S„o Paulo and a regional DANCHAMB¥s representative in Paran· State.

He had a preponderant lead in addressing sustainable issues, leading the Novozymes delegation to the UNCSD Rio+20 Summit in 2012 and recently COP 21 and has been actively engaged with and spoken on behalf of business at UNFCCC meetings since 2009.

In 2010 he was awarded with a Diploma of the Danish Exports Association and Prince Henrik's Medal of Honour in recognition to ìOutstanding Services to Trade Relations between Denmark and Brazilî. In 2012 Mr. Fernandes was honored by the Danish Government with the title of ìHonorary Consul of the Kingdom of Denmarkî for the States of Paran· and Santa Catarina in Brazil.

Since 2013 he has being one of the directors and co-founders of the Brazilian Association of Industrial Biotechnology (ABBI).

He is president and co-founder of the Princess Benedikte Institute. Also, he is representative of Novozymes Latin America Ltda. at Global Compact Brazilian Network and member of two Working Groups: Climate & Energy and Food & Agriculture.

BS in Chemistry by the Pontifical Catholic University of Paran· (PUC/PR).

He currently participates as Master's Degree candidate in Governance & Sustainability at ISAE/ FGV - Institute of Business and Economics in Curitiba ñ Paran·.

Jaime Finguerut, Industrial Strategic Development, Sugarcane Technology Center (CTC), (Brazil)

Jaime Finguerut, chemical engineer, is a Technical Advisor for CTC. He has more than 35 years of experience in the development of biotechnology processes applied to the biofuels industry in Brazil. He led the big increases in yield and productivity of the industrial, large scale, non-asseptic ethanol fermentation process where Brazil is a global leader. He joined CTC ñ Centro de Tecnologia Canavieira in 1980.

Previously, Jaime worked as teacher and researcher for FEI ñ Faculdade de Engenharia Industrial at S„o Bernardo do Campo, making part of a network of biotechnology researchers at University of S„o Pauloí Escola PolitÈcnica and IPT ñ Instituto de Pesquisas TecnolÛgicas as well as at Escola de Engenharia Mau·, developing several aspects of yeast fermentation and physiology. He also worked at CETESB, the state of S„o Pauloí Environment Protection agency developing the anaerobic biodigestion process to convert residues in biogas for energy.

Cristián Hernández, Chief Operting Officer, Andes Biotechnologies (Chile)

Cristián Hernández is a Molecular Biotechnology Engineer from the University of Chile, with a Masters in Bioscience Enterprise from the University of Cambridge. Throughout his career, Cristián has worked at the intersection of science and business. He is currently the Chief Operations Officer of Andes Biotechnologies and Director of Business Development at Fundación Ciencia & Vida in Chile. Cristian is also an Angel Investor and Mentor. He has invested a considerable amount of time and energy supporting the development of science and business initiatives in Chile, such as Redbionova, Latin America’s best on-line and networking community for bio-entrepreneurs.

Jorge Kalil Director, Butantan Institute (Brazil)

Jorge Kalil is Professor of Clinical Immunology and Allergy, Director of the Laboratory of Immunology, Heart Institute, School of Medicine, University of Sao Paulo and Director of Instituto Butantan. He is President of IUIS (International Union of Immunologial Societies) and adjunct Professor of GWU. Graduated in Medicine (1977), Doctor of Science in Human Biology, University of Paris VII, in Jean Dausset’s laboratory (Nobel Prize 1980 for HLA). Visiting Professor and Co-Director of the Laboratory HLA, Stanford School of Medicine (1991) and International Scholar of Howard Hughes Medical Institute (1991-1995). Kalil is dedicated to the study of the mechanisms of immunological recognition and distinction of self and no self with over 350 publications (ISI) and several patents. He coordinates iii – Institute for Investigative Immunology, a National Institute of Science and Technology since 2001. He co-chairs the Brazilian FOCIS Center of Excellence. He is a member of the Brazilian Academy of Science (1998) and Grand Cross of the National Order of Scientific Merit. The French President honored him with the National Order of Merit. He received the Biology Prize of TWAS and Fundação Conrado Wessel Prize. He is “Doctor Honoris Causa” by “Université Paris Sorbonne” and fellow of the Royal College of Physicians (FRCP). He represents Brazil in International Institute of Genetic Engineering and Biotechnology.

Ana Laura Lopes, Director of BD for Physical Sciences, Boston University / Board Member, SciBr Foundation (USA)

Ana joined the Office of Technology Development at Boston University in May 2014. As Director of Business Development, she manages BU’s portfolio of Physical Sciences inventions with the mission to commercialize the university’s technologies, develop stronger university-industry relations as well as support BU’s entrepreneurial activities.

Prior to the OTD, Ana was a founding partner at a consulting company where she connected Brazilian technology based companies with Boston’s innovation ecosystem. Ana also worked as a Business Development Strategist at E Ink where she was responsible for developing strategies for new markets and applications for the company’s leading electronic paper display (EPD) technology. In addition, Ana has many years of experience with technology transfer, having worked at the Technology Licensing Office at the Massachusetts Institute of Technology (MIT). As a Technology Licensing Associate, she assisted with all aspects of technology commercialization from IP evaluation to strategy development and deal negotiations, with a focus on technologies in Clean Energy, Chemistry, Chemical Engineering and Materials.

Ana is also a board member of SciBr Foundation; a charitable, educational and scientific organization dedicated to promoting meaningful cultural and cooperative exchange between the US and Brazil in education, science, innovation and research. She is also a mentor to several startup companies. She is a graduate from the University of Toronto where she earned an Honours Bachelor of Science in Astronomy and Physics and is currently pursuing her Master in Business Administration.


Christophe Luguel, International Affairs Manager, Competitiveness Cluster Industries & Agro-Ressources (IAR), (France)

Christophe Luguel has a Master of Engineering in Agronomy (AgroParisTech, France). After three years spent in a R&D Centre (Hoechst), he occupied various positions in sales, marketing and business development in chemical and biotech companies. He joined the French Competitiviness biocluster “Industries & Agro-Ressources” (IAR) late 2007, as Head of International Affairs.

He was also the coordinator of the FP6 CSA project “Biorefinery Euroview” (2007-2009) and was involved (WP leader) in the FP7 CSA project Star-Colibri (2009-2011). Within this project, he coordinated the development of the “Joint European Biorefinery Vision for 2030” and of the “European Biorefinery Joint Strategic Research Roadmap”. He is board member of the Bio-Based Industries Joint Undertaking is a new €3.7 billion Public-Private Partnership between the EU and the Bio-based Industries Consortium. Founder of the intercluster 3BI (Brokering Bio-Based Innovation) composed by IAR Cluster, Bioeconomy Cluster focuses on wood (Germany), BioVale focuses on biowastes (UK) and Biobased Delta focuses on a range of novel biological resources for its chemical industry (The Netherlands).

Bernardo Silva, Executive President, Brazilian Industrial Biotechnology Association (ABBI), (Brazil)

Bernardo Silva was appointed Executive President of the Brazilian Industrial Biotechnology Association (ABBI) in January 2015. Prior to joining ABBI, Bernardo worked at the World Economic Forum headquarters in Cologny, Switzerland, overseeing corporate and membership affairs in South America. He also served in a variety of government affairs and policy advocacy roles within the Brazilian Trade and Investment Promotion Agency (ApexBrasil), and with the United States Department of Agriculture (USDA) in Brasilia, Brazil.

Bernardo earned his MA degree from Tufts Universityís Fletcher School of Law and Diplomacy, MBA from FundaÁ„o Get˙lio Vargas (FGV), and holds a BS degree in Economics from UniCEUB. Bernardo was also the first Brazilian to ever be accepted as a Global Leadership Fellow at the World Economic Forum.

Alan Vanderborght, Managing Director & Chief Executive Officer, Kybora 

18+ years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol- Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.